For the Inventor, By the Inventor

Enter assignee name

La Jolla, CA, United States of America

Calcimedica, Inc.

USPTO Granted Patents = 35

% Expired Patents = 25.7

CIPO Patents = 1

EPO Patents = 8

Trademarks = 3

Forward Citations = 150

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Jeffrey Paul Whitten (24 out of 68 patents)

Kenneth Stauderman (20 out of 23 patents)

Evan W Rogers (19 out of 47 patents)

4. Jianguo Cao (19 out of 84 patents)

5. Zhijun Wang (19 out of 20 patents)

6. Yazhong Pei (18 out of 29 patents)

7. Jonathan Bryant Grey (18 out of 78 patents)

8. Gonul Velicelebi (16 out of 29 patents)

9. Brian Dyck (15 out of 28 patents)

10. Jack Roos (9 out of 10 patents)

11. Michael Dunn (7 out of 8 patents)

12. Paul J Digregorio (3 out of 3 patents)

13. Kari Lynn Ohlsen (3 out of 5 patents)

14. Sudarshan Hebbar (2 out of 2 patents)

15. Soan Cheng (2 out of 31 patents)

35 patents: Sort by Forward Citations

1. 12544371 - Methods and compositions for treating acute lung injury and acute respiratory distress syndrome (2026-02-10),

2. 12522589 - Synthesis of CRAC channel inhibitors (2026-01-13),

3. 11905248 - Compounds that modulate intracellular calcium (2024-02-20),

4. 11752148 - Pyrazine-containing compound (2023-09-12),

5. 11439639 - Pyrazine-containing compound (2022-09-13),

6. 11311535 - Pancreatitis treatment (2022-04-26),

7. 10821109 - Pyrazine-containing compound (2020-11-03),

8. 10703722 - Compounds that modulate intracellular calcium (2020-07-07),

9. 10478435 - Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury (2019-11-19),

10. 10336738 - Compounds that modulate intracellular calcium (2019-07-02),

11. 9856240 - Compounds that modulate intracellular calcium (2018-01-02),

12. 9611263 - Compounds that modulate intracellular calcium (2017-04-04),

13. 9512116 - Compounds that modulate intracellular calcium (2016-12-06),

14. 9353099 - Compounds that modulate intracellular calcium (2016-05-31),

15. 9120751 - Compounds that modulate intracellular calcium (2015-09-01),

Calcimedica, Inc. is a biopharmaceutical company focused on the development of novel small molecule drugs for the treatment of rare and serious diseases. Their mission is to improve the lives of patients by creating innovative therapies that target calcium dysregulation, a common characteristic of many diseases. By combining deep knowledge of calcium signaling with cutting-edge drug discovery technologies, Calcimedica is committed to delivering transformative medicines to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Calcimedica, Inc.

35 Patents

#18 in La Jolla, CA

#2,305 in California

#9,710 in US

#19,126 in the World

La Jolla, CA, United States of America

Calcimedica, Inc.

Forward Citations = 150

21 inventors:

Jeffrey Paul Whitten (24 out of 68 patents)

Kenneth Stauderman (20 out of 23 patents)

Evan W Rogers (19 out of 47 patents)

4. Jianguo Cao (19 out of 84 patents)

5. Zhijun Wang (19 out of 20 patents)

Please report any incorrect information to [email protected]

Loading…